- Home
- ATAI vs ISPR Comparison
ATAI vs ISPR Comparison
Compare ATAI & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- ISPR
- Stock Information
- Founded
- ATAI 2018
- ISPR 2019
- Country
- ATAI Germany
- ISPR United States
- Employees
- ATAI N/A
- ISPR N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- ATAI Health Care
- ISPR Health Care
- Exchange
- ATAI Nasdaq
- ISPR Nasdaq
- Market Cap
- ATAI 444.7M
- ISPR 152.0M
- IPO Year
- ATAI 2021
- ISPR 2023
- Fundamental
- Price
- ATAI $4.85
- ISPR $3.04
- Analyst Decision
- ATAI Strong Buy
- ISPR Strong Buy
- Analyst Count
- ATAI 3
- ISPR 2
- Target Price
- ATAI $13.33
- ISPR $10.00
- AVG Volume (30 Days)
- ATAI 4.7M
- ISPR 52.5K
- Earning Date
- ATAI 11-12-2025
- ISPR 09-15-2025
- Dividend Yield
- ATAI N/A
- ISPR N/A
- EPS Growth
- ATAI N/A
- ISPR N/A
- EPS
- ATAI N/A
- ISPR N/A
- Revenue
- ATAI $2,309,000.00
- ISPR $127,494,304.00
- Revenue This Year
- ATAI $712.99
- ISPR $61.29
- Revenue Next Year
- ATAI N/A
- ISPR N/A
- P/E Ratio
- ATAI N/A
- ISPR N/A
- Revenue Growth
- ATAI 510.85
- ISPR N/A
- 52 Week Low
- ATAI $1.03
- ISPR $2.09
- 52 Week High
- ATAI $5.34
- ISPR $7.79
- Technical
- Relative Strength Index (RSI)
- ATAI 64.59
- ISPR 47.88
- Support Level
- ATAI $4.50
- ISPR $3.03
- Resistance Level
- ATAI $4.75
- ISPR $3.43
- Average True Range (ATR)
- ATAI 0.28
- ISPR 0.26
- MACD
- ATAI -0.03
- ISPR -0.01
- Stochastic Oscillator
- ATAI 76.02
- ISPR 11.70
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.